Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Birch-SPIRE Safety and Efficacy Study in Rhinitis
NCT02478060Phase 2Completed
- Sponsor
- NIOX Group
- Start
- Jul 2015
- Primary completion
- Jul 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of Birch-SPIRE in allergic rhinitis (AR), sponsored by NIOX Group. Started Jul 2015; status: completed.
02
Drugs
Birch-SPIRE
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02478060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02478060.